BD Live! enables users to evaluate assets against one another in a data-driven and objective way. From pre-clinical to approved drugs, BD Live! aggregates scientific, medical and business information and determines the likelihood of a value creation event such as a clinical trial advancement, licensing transactions, and mergers and acquisitions.
Learn more about our objective asset comparison.
